DNM1L and Huntington disease: Thus, an increase in Drp1 could assist in mitochondrial degradation, as well as in its corresponding degradation and dysfunction that leads to the both the increase in and vulnerability for the apoptosis that occurs within the cells of Huntington’s Disease patients [64].